PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.02%
Revenue growth under 50% of MCHP's 10.82%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
134.81%
Gross profit growth above 1.5x MCHP's 15.09%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-2.59%
Negative EBIT growth while MCHP is at 140.04%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-2.59%
Negative operating income growth while MCHP is at 132.00%. Joel Greenblatt would press for urgent turnaround measures.
35.09%
Net income growth under 50% of MCHP's 87.97%. Michael Burry would suspect the firm is falling well behind a key competitor.
25.00%
EPS growth under 50% of MCHP's 70.34%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
25.00%
Diluted EPS growth under 50% of MCHP's 70.34%. Michael Burry would worry about an eroding competitive position or excessive dilution.
19.32%
Share count expansion well above MCHP's 0.33%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
19.32%
Diluted share count expanding well above MCHP's 0.33%. Michael Burry would fear significant dilution to existing owners' stakes.
-12.55%
Dividend reduction while MCHP stands at 10.17%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
14.29%
OCF growth under 50% of MCHP's 33.85%. Michael Burry might suspect questionable revenue recognition or rising costs.
6.22%
FCF growth under 50% of MCHP's 34.43%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
38.83%
10Y revenue/share CAGR at 75-90% of MCHP's 51.09%. Bill Ackman would press for new markets or product lines to narrow the gap.
13.74%
Positive 5Y CAGR while MCHP is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-0.50%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
10.25%
Positive 3Y OCF/share CAGR while MCHP is negative. John Neff might see a big short-term edge in operational efficiency.
258.23%
Positive 10Y CAGR while MCHP is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-12.15%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
99.65%
Positive short-term CAGR while MCHP is negative. John Neff would see a clear advantage in near-term profit trajectory.
15.18%
Below 50% of MCHP's 145.07%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-0.88%
Negative 5Y equity/share growth while MCHP is at 14.52%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-27.07%
Negative 3Y equity/share growth while MCHP is at 17.81%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-19.54%
Cut dividends over 10 years while MCHP stands at 180.63%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
48.99%
Below 50% of MCHP's 175.02%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
-6.13%
Negative near-term dividend growth while MCHP invests at 81.65%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-12.16%
Firm’s AR is declining while MCHP shows 10.99%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-8.02%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.07%
Positive asset growth while MCHP is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-18.17%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
1.05%
We have some new debt while MCHP reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
0.30%
SG&A declining or stable vs. MCHP's 4.80%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.